JPAD-Journal of Prevention of Alzheimers Disease
Scope & Guideline
Fostering Collaboration for a World Without Alzheimer's
Introduction
Aims and Scopes
- Prevention Strategies and Interventions:
The journal emphasizes the development and evaluation of various prevention strategies aimed at delaying or preventing cognitive decline and Alzheimer's disease. This includes lifestyle modifications, dietary interventions, and community-based programs. - Biomarkers and Diagnostic Tools:
Research on biomarkers for early detection and diagnosis of Alzheimer's disease is a core focus. This includes studies on blood, imaging, and genetic biomarkers that can help identify individuals at risk and monitor disease progression. - Cognitive Function Assessment:
JPAD publishes studies that explore cognitive assessments and their relevance in clinical and community settings. This includes the validation of new cognitive tests and the use of digital tools to evaluate cognitive function. - Health Equity and Access:
The journal addresses disparities in Alzheimer's disease research and treatment, focusing on recruitment strategies for underrepresented populations in clinical trials and the role of social determinants of health. - Innovative Therapeutic Approaches:
Research into new therapeutic strategies, including pharmacological and non-pharmacological interventions, is a significant area of interest. This includes studies on the efficacy of new drugs, dietary supplements, and lifestyle changes. - Longitudinal Studies and Cohort Analyses:
JPAD often features longitudinal studies that track cognitive decline over time, providing insights into the progression of Alzheimer's disease and associated risk factors.
Trending and Emerging
- Digital Health Interventions:
The use of digital technologies for cognitive assessments, monitoring, and interventions is rapidly gaining traction. Research exploring how mobile applications and online platforms can enhance cognitive health is increasingly prevalent. - Personalized Medicine Approaches:
There is a growing emphasis on personalized medicine in Alzheimer's research, with studies focusing on tailoring interventions based on individual genetic, lifestyle, and health profiles. - Multidomain Lifestyle Interventions:
Research on multidomain interventions that combine dietary, physical, and cognitive activities to prevent cognitive decline is on the rise, reflecting an integrated approach to Alzheimer's prevention. - Community Engagement in Research:
The journal is increasingly highlighting the importance of community engagement in Alzheimer's research, particularly in recruiting diverse populations for clinical trials and addressing health disparities. - Neuroinflammation and Immune Response:
Emerging research into the role of neuroinflammation and the immune response in Alzheimer's disease is gaining prominence, with studies investigating therapeutic strategies targeting these pathways. - Social Determinants of Health:
There is an increasing focus on how social determinants, such as socioeconomic status and access to care, impact cognitive health and the progression of Alzheimer's disease.
Declining or Waning
- Historical Epidemiological Studies:
There has been a noticeable decrease in the publication of traditional epidemiological studies that solely focus on historical data without integrating contemporary methods or innovative approaches. - Single-Factor Risk Assessments:
Research solely emphasizing single-factor risk assessments for Alzheimer's disease is declining. The trend is moving towards multifactorial approaches that consider a combination of genetic, environmental, and lifestyle factors. - Basic Science Research:
Studies focused exclusively on basic biological mechanisms of Alzheimer's disease without practical implications for prevention or intervention are becoming less frequent, as the journal emphasizes translational research. - Pharmacological Monotherapy Trials:
There is a waning interest in studies that evaluate the effectiveness of pharmacological monotherapies for Alzheimer's treatment, as the focus shifts towards combination therapies and holistic approaches.
Similar Journals
Multiple Sclerosis Journal-Experimental Translational and Clinical
Leading the Charge in Neurological Research and TreatmentMultiple Sclerosis Journal-Experimental Translational and Clinical, published by SAGE Publications, Inc., is an essential open-access platform since 2015 dedicated to advancing research in the field of multiple sclerosis and related neurological disorders. With an ISSN of N/A and an E-ISSN of 2055-2173, the journal aims to bridge the gap between experimental studies and clinical applications, offering valuable insights into cellular and molecular neuroscience as well as clinical neurology. The journal holds a reputable Q3 ranking in Cellular and Molecular Neuroscience and a Q2 ranking in Neurology (Clinical) for 2023, indicating its significant contribution to these fields. Positioned at the intersection of scientific discovery and clinical practice, the Multiple Sclerosis Journal serves as an indispensable resource for researchers, clinicians, and students dedicated to improving outcomes for individuals affected by multiple sclerosis and related disorders. With a Scopus ranking of #163/400 in Medicine - Neurology and #67/97 in Neuroscience, this journal continues to play a pivotal role in shaping the future of neurological research and therapy.
Frontiers in Aging Neuroscience
Bridging Science and Aging for Cognitive Excellence.Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
Enhancing Elderly Minds: Pioneering Research in Geriatric PsychiatryAmerican Journal of Geriatric Psychiatry, published by Elsevier Science Inc, stands as a leading journal in the fields of geriatrics and gerontology, as well as psychiatry and mental health, recognized with a Q1 ranking in both categories for 2023. With a robust ISSN of 1064-7481 and E-ISSN 1545-7214, this journal has been a vital resource since its inception in 1993, contributing to the academic discourse surrounding the mental health of older adults. The journal focuses on publishing high-quality research and reviews that address the complexities of psychiatric disorders in geriatric populations, making it essential reading for researchers, professionals, and students dedicated to enhancing the mental well-being of elderly individuals. Notably, it achieves impressive Scopus rankings, sitting at the 5th percentile in Geriatrics and Gerontology and 24th percentile in Psychiatry and Mental Health, underscoring its impact and relevance in the academic community. While it does not offer open access, the journal's comprehensive content is vital for those looking to stay informed on the latest advancements in geriatric psychiatry. For more information, readers can access it via Elsevier's educational platforms.
Dementia and Geriatric Cognitive Disorders Extra
Unlocking insights into dementia and cognitive disorders.Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.
Psychogeriatrics
Exploring the intersection of psychiatry and gerontology.Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.
Aging Brain
Fostering Innovation in Gerontology and NeuroscienceAging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
Exploring the Intersection of Mind and BrainThe JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, published by AMER PSYCHIATRIC PUBLISHING, INC, stands as a pivotal resource in the interdisciplinary fields of psychiatry, neurology, and mental health. With a history spanning from 1989 to 2024, this esteemed journal, identified by the ISSN 0895-0172 and E-ISSN 1545-7222, provides a platform for cutting-edge research and clinical insights into neuropsychiatric disorders. As of 2023, the journal is recognized in Q2 quartiles for Medicine (miscellaneous), Neurology (clinical), and Psychiatry and Mental Health, showcasing its significant impact within these domains, as evidenced by its Scopus rankings placing it in the 67th and 65th percentiles respectively. The journal emphasizes the importance of advancing knowledge through empirical studies, case reports, and reviews, making it an invaluable asset for researchers, clinicians, and students dedicated to understanding the complexities of the human brain and its psychological manifestations. Although the journal does not currently offer open access, it remains essential for those seeking to stay at the forefront of neuropsychiatric advancements.
Cognitive and Behavioral Neurology
Unraveling the Complexities of Neurological DisordersCognitive and Behavioral Neurology is a prominent peer-reviewed journal dedicated to advancing the understanding of cognitive and behavioral aspects of neurological disorders. Published by Lippincott Williams & Wilkins, this journal has established itself as a vital resource for researchers, clinicians, and students in the fields of cognitive neuroscience, neuropsychology, and psychiatry. With an ISSN of 1543-3633 and an E-ISSN of 1543-3641, it offers a robust platform for the dissemination of high-quality research, as evidenced by its positioning in the Q3 quartiles across various categories, including Cognitive Neuroscience and Psychiatry. The journal, which has been actively publishing since 2003, encourages innovative studies that explore the intersection of cognition and behavior in neurological contexts. As a vital contributor to the academic dialogue on these topics, it provides an essential archive of findings and discussions that inform clinical practice and educational approaches, reflecting its commitment to improving patient outcomes and enhancing neurological science.
Cerebral Circulation-Cognition and Behavior
Bridging Neuroscience with Behavioral InsightsCerebral Circulation-Cognition and Behavior is an impactful journal published by Elsevier that focuses on the intersections of cerebral circulation, cognitive function, and behavioral science. Since its establishment in 2020, the journal has provided a vital platform for researchers and professionals in the fields of Behavioral Neuroscience, Biological Psychiatry, and Cognitive Neuroscience. With a current classification in the Q3 quartile across several neuroscience categories and a promising trajectory during its converged years (2020-2024), the journal highlights significant advancements in our understanding of the neural underpinnings of behavior. Although it is not open access, its commitment to quality research makes it an essential resource for anyone engaged in neurological, cognitive, and psychiatric studies. As discoveries in these fields continue to grow, Cerebral Circulation-Cognition and Behavior remains dedicated to disseminating influential findings that bridge the gap between cognition, behavior, and neural health.
Cancer Prevention Research
Empowering research for a healthier tomorrow.Cancer Prevention Research, published by the American Association for Cancer Research, is a leading journal dedicated to advancing our understanding of cancer prevention strategies and their implementation in public health. With an ISSN of 1940-6207 and E-ISSN 1940-6215, this journal serves as a pivotal platform for researchers, healthcare professionals, and students who are committed to unraveling the complexities of cancer etiology and preventive measures. Since its inception in 2008, the journal has carved a niche in the scientific community, achieving notable rankings including Q2 in Cancer Research and Q1 in both Medicine (miscellaneous) and Oncology, highlighting its significance in disseminating influential research. Cancer Prevention Research is indexed in Scopus, reflecting a robust impact factor, and features a range of articles that address the preventive aspects of cancer to promote healthier populations. With access options available, it invites contributions that bridge laboratory findings with epidemiologic insights, making it an essential resource for anyone dedicated to reducing the burden of cancer globally.